Instrument Business Outlook: Volume 30 - Issue 4
-
Advertisement
-
FY22 US Budget Proposal Brings Benefits for the NIH
-
IBO Survey Finds Chinese Instrument Makers Gaining Ground
-
Instrument Quality
-
Five-Year Plan Funding for Instruments
-
Survey Demographics
-
IBO Indexes Begin 2021 with Robust Growth in the First Quarter
-
End-Markets
-
Regions
-
Product Lines
-
Quarterly and Full-Year Forecasts
-
Executive Briefing
-
FTC Makes Illumina Case Announcement
-
PerkinElmer Further Invests in Immunodiagnostics
-
Gamma Biosciences Buys Stake in Transfection Company for Viral Vector Manufacturing
-
Dissolution Testing Firm Recapitalized
-
Singular Genomics Completes IPO
-
CELLINK Announced Third and Fourth Purchases This Year
-
Lab Chemical Firm Acquired
-
First Quarter Results: Agilent Technologies, Bio-Techne, Bruker, MilliporeSigma and QIAGEN
-
Agilent Continues its Winning Streak for 2021
-
Bio-Techne Post Strong Instrument Sales for Fiscal Third Quarter
-
Bruker’s BSI Business Starts 2021 with Strength
-
MilliporeSigma Maintains Bioprocess Growth
-
QIAGEN Posts Broad-Based Gains Across its Businesses
-
IBO Stock Index Finishes May in Mixed Territory
-
Laboratory Instruments and Products Stock Index
-
Diversified Instrumentation Stock Index
-
International Stocks
-
Market Profile: Electron Energy Loss Spectroscopy (EELS)
-
Leading Vendors
-
Largest Markets
-
Instrument Cost
-
Industry Watch
-
Region Watch
-
News
-
Broad-based Companies
-
Company Announcements
-
Sales & Orders of Note
-
Life Science Instruments
-
Company Announcements
-
Gene-based Analysis
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Cell-based Analysis
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Protein-based Analysis
-
Company Announcements
-
Sequencing
-
Company Announcements
-
Product Introductions
-
Sales & Order of Note
-
Materials Characterization
-
Company Announcements
-
Sales & Orders of Note
-
Bottom Line